Tom Amick

Nessuna posizione attualmente

Health Technology

Finance

Profilo

Prior to joining Quaker BioVentures' Advisory Board, Mr. Amick retired from a highly successful 30 year career with Johnson & Johnson.
After starting the biotechnology/oncology business within J&J, Mr. Amick advanced to the position of Vice President of the Oncology Franchise where he developed one of the most successful businesses in the history of J&J.
Mr. Amick held positions of increasing responsibility including, President of Janssen-Ortho, President of Ortho Biotech Europe, and Vice President of J&J Development Corporation.

Precedenti posizioni note di Tom Amick

Società	Posizione	Fine
Quaker Partners Management LP Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania.	Investitore di Private Equity	30/03/2010
Janssen, Inc. Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada.	Corporate Officer/Principal	-
JOHNSON & JOHNSON	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Tom Amick

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private